| scholarly article | Q13442814 |
| P50 | author | Vorasuk Shotelersuk | Q73205336 |
| P2093 | author name string | W A Gahl | |
| M Huizing | |||
| N A Avila | |||
| M Brantly | |||
| C Lucero | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| patient | Q181600 | ||
| Hermansky-Pudlak syndrome | Q1506216 | ||
| P304 | page(s) | 129-136 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1 | |
| P478 | volume | 117 |
| Q36565348 | A divalent interaction between HPS1 and HPS4 is required for the formation of the biogenesis of lysosome-related organelle complex-3 (BLOC-3). |
| Q30814335 | A novel immunocytochemical assay for the detection of serotonin in platelets |
| Q40584900 | Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome |
| Q37443271 | Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. |
| Q36457840 | An immunoblotting assay to facilitate the molecular diagnosis of Hermansky-Pudlak syndrome |
| Q21284167 | Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin |
| Q35596104 | Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis |
| Q24678933 | Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4 |
| Q34338971 | Cellular, molecular and clinical characterization of patients with Hermansky-Pudlak syndrome type 5. |
| Q36040475 | Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease |
| Q30362039 | Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. |
| Q51111803 | Clinical and molecular phenotyping of a child with Hermansky-Pudlak syndrome-7, an uncommon genetic type of HPS. |
| Q52352981 | Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. |
| Q35541668 | Clinical, molecular, and cellular features of non-Puerto Rican Hermansky-Pudlak syndrome patients of Hispanic descent |
| Q47998881 | Correlation of ultra-low dose chest CT findings with physiologic measures of asbestosis |
| Q41839013 | Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis |
| Q37273809 | Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome |
| Q35628568 | Disorders of lung matrix remodeling |
| Q33799623 | Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis |
| Q35219750 | Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome |
| Q36013730 | Early interstitial lung disease in familial pulmonary fibrosis |
| Q44070468 | Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome |
| Q37351580 | Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome |
| Q50088162 | Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. |
| Q24626239 | Genetic interstitial lung disease |
| Q36485998 | Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis |
| Q36905348 | Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization |
| Q51577302 | Hermansky-Pudlak Syndrome. |
| Q64120927 | Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising |
| Q34156519 | Hermansky-Pudlak syndrome and related disorders of organelle formation |
| Q37186232 | Hermansky-Pudlak syndrome in the peripartum period. |
| Q42428572 | Hermansky-Pudlak syndrome interstitial pneumonia: it's the epithelium, stupid! |
| Q37222169 | Hermansky-Pudlak syndrome type 1 in patients of Indian descent |
| Q24536114 | Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency |
| Q34186874 | Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics |
| Q53624773 | Hermansky-Pudlak syndrome type 4 in a patient from Sri Lanka with pulmonary fibrosis. |
| Q92395130 | Hermansky-Pudlak syndrome: Mutation update |
| Q47634553 | Hermansky-Pudlak syndrome: Report of two patients with updated genetic classification and management recommendations |
| Q34485728 | Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function |
| Q35009608 | Hermansky-Pudlak syndrome: vesicle formation from yeast to man. |
| Q34453509 | Hermansky-pudlak syndrome complicated by pulmonary fibrosis: radiologic-pathologic correlation and review of pulmonary complications |
| Q40485723 | Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism |
| Q34567878 | Ileal Crohn's disease in a woman with Hermansky-Pudlak syndrome |
| Q99609211 | Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity? |
| Q47757346 | Inflammatory response and cathepsins in silica-exposed Hermansky-Pudlak syndrome model pale ear mice |
| Q35718958 | Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease |
| Q82346436 | Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype |
| Q34781472 | Lung volumes and emphysema in smokers with interstitial lung abnormalities |
| Q37198871 | Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome |
| Q36955310 | MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro |
| Q35129447 | Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking |
| Q90751418 | Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report |
| Q36850698 | Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis |
| Q34609301 | Platelet alpha granules in BLOC-2 and BLOC-3 subtypes of Hermansky-Pudlak syndrome |
| Q64039613 | Precise therapeutic gene correction by a simple nuclease-induced double-stranded break |
| Q90590234 | Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis |
| Q41631897 | Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. |
| Q36493952 | Pulmonary function testing in idiopathic interstitial pneumonias |
| Q34490580 | Pulmonary function tests in interstitial lung disease: what role do they have? |
| Q53293292 | Pulmonary involvement in early rheumatoid arthritis patients. |
| Q30462793 | Rab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells |
| Q58112708 | Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis |
| Q42065927 | Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. |
| Q49323930 | The Immunome in Two Inherited Forms of Pulmonary Fibrosis. |
| Q36488735 | The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome |
| Q39040828 | Tissue remodelling in pulmonary fibrosis |
| Q26779192 | Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs |
| Q47650335 | Viral load and outcome in SARS infection: the role of personal protective equipment in the emergency department |
| Q79668026 | [Pulmonary fibrosis in Hermansky-Pudlak syndrome is not fully usual] |
Search more.